Des Moines runs hotter than Polk County and Iowa on obesity, Iowa Medicaid excludes the weight-loss indication, and the city's transparent prices escalate by dose or after eight weeks.
39.4% of Des Moines adults have obesity (CDC PLACES 2025 release, BRFSS 2023, place-level crude prevalence) 1, about 2.4 points above Polk County's 37.0% 2 and 1.6 points above Iowa's 37.8% 3, both BRFSS 2023. The city is the obesity hotspot inside its own metro of 740,131 5.
What that costs a Des Moines household depends on two things: a state drug list that excludes the weight-loss indication, and a local market that publishes its prices and then raises them.
Iowa Medicaid does not cover GLP-1s for the weight-loss indication. The state's own preferred drug list effective January 1, 2026 lists Wegovy and Zepbound under comment code 12, defined in the PDL legend as PA Required. Weight loss indication not covered, and the linked prior-authorization form covers only Wegovy for cardiovascular-risk reduction and Zepbound for obstructive sleep apnea, stating that payment for excluded weight-loss uses will be denied 8.
Ozempic and Mounjaro remain covered for type 2 diabetes with prior authorization, typically after a metformin trial, and Iowa Health Link managed-care plans follow the state PDL exclusion 8. KFF's Jan 16, 2026 analysis counts 13 state Medicaid fee-for-service programs covering GLP-1s for obesity treatment, and Iowa is not among them 9; glpchart.com's Iowa tracker, updated July 20, 2026 and citing the 2025-Q3 PDL review, matches 10. Verified Aug 27, 2026.
Des Moines is a rare price-transparent market, and the pattern in that transparency is that every published price climbs on you. Longevity DSM, by Iowa IV, is the only price-published provider located in Des Moines proper and posts a full four-week dose ladder: semaglutide $199 at 0.25 mg rising by dose to $599 at 2.5 mg, and tirzepatide $299 at 2.5 mg rising to $699 at 12.5 mg, with programs including a free monthly Lipo-B12 or Lipo-Carnitine injection, a monthly Fit3D/SECA body-composition scan, and RD meal planning. A limited-time promo, $50 off the 0.25 mg semaglutide dose and $100 off all other doses, ends Aug 31, 2026, so the regular ladder is the durable price (checked Aug 27, 2026) 11.
WellForm MD in Ankeny publishes $195 for a first month of virtual compounded semaglutide, reflecting a $25 first-month adjustment, and $325/month for Ankeny compounded care including medication, with price varies by dose band stated outright, alongside $150/month virtual brand care and $300/month Ankeny brand care as management fees with the brand medication paid separately to the pharmacy; tirzepatide mirrors the structure at $295 first month virtual and $475/month Ankeny compounded 12. Des Moines Plastic Surgery in West Des Moines and Ankeny runs a new-guest offer of $499 each month for the first two months with mandatory up-front commitment to the full eight-week dosing program, after which month-to-month continuation is $799/month 13.
Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans, $816 and $1,416 per year, billed annually, the same in Des Moines as everywhere else and the same at every dose.
Des Moines inverts the usual shortage narrative. UnityPoint Clinic Weight Loss in West Des Moines is an ACS/ASMBS MBSAQIP-accredited Comprehensive Center for Metabolic and Bariatric Surgery 14, MercyOne Des Moines Weight Management Center offers bariatric surgery, medical weight loss, and nutrition counseling under national accreditation 15, UnityPoint lists obesity-medicine providers practicing in Des Moines proper, and the independent group Iowa Weight Loss Specialists operates in the metro. The University of Iowa Health Care academic center is about two hours east in Iowa City, and Des Moines residents do not need to make that drive for comprehensive obesity care.
The real gap is narrower and financial. Polk County carries three active primary-care HPSA designations per HRSA's Bureau of Health Workforce file (downloaded Aug 27, 2026): the LI Des Moines Area Low-Income Population HPSA (score 14 of 25, designated Aug 15, 2025, designation population 85,774), plus two FQHC-based designations, Primary Health Care Inc. (score 19, population 109,145) and Proteus Inc. (score 19, population 35,565). A prior low-income Des Moines designation (score 17, designated 2021) was withdrawn July 1, 2026 and superseded by the 2025 designation. Roughly 86,000 low-income Des Moines-area residents live in a federally designated shortage population even though the metro as a whole is provider-rich 7.
For a reader who already has local programs available but no coverage for the indication and a price that escalates at every titration step, a flat national price is the variable that changes. See the Iowa GLP-1 overview for statewide context.
Astra treats patients in Iowa through state-licensed physicians.
No — not for the weight-loss indication. Iowa Medicaid's preferred drug list effective January 1, 2026 lists Wegovy and Zepbound under comment code 12, defined as 'PA Required. Weight loss indication not covered,' and the state's prior-authorization form covers only Wegovy for cardiovascular-risk reduction and Zepbound for obstructive sleep apnea. Ozempic and Mounjaro remain covered for type 2 diabetes with prior authorization, typically after a metformin trial, and Iowa Health Link managed-care plans follow the same PDL exclusion. Verified August 27, 2026.
Among metro providers that publish prices: Longevity DSM in Des Moines posts a four-week dose ladder running $199 (0.25 mg) to $599 (2.5 mg) at regular prices; WellForm MD in Ankeny starts virtual compounded care at $195 for the first month, then in-person compounded care from $325/month with price varying by dose band; Des Moines Plastic Surgery's program runs $499/month for the first two months, then $799/month. All three publish their prices — rare for a tier-2 metro — but every one of them climbs, either by dose or after the introductory window.
Because most local programs price by the vial. Longevity DSM's published ladder climbs from $199 to $599 for semaglutide and $299 to $699 for tirzepatide per four-week supply as the dose rises, and WellForm MD's Ankeny compounded price 'varies by dose band.' Standard titration moves most patients from a starter dose toward a maintenance dose over several months, so the advertised entry price is rarely what you pay by month four. Flat-rate telehealth plans charge the same monthly price at every dose.
You don't need to travel. UnityPoint Clinic Weight Loss in West Des Moines is an MBSAQIP-accredited Comprehensive Center for Metabolic and Bariatric Surgery, MercyOne Des Moines Weight Management Center offers accredited bariatric and medical weight-loss care, UnityPoint lists obesity-medicine providers in Des Moines proper, and Iowa Weight Loss Specialists practices in the metro. University of Iowa Health Care is about two hours east, but for most patients the barrier in Des Moines is coverage and cash price, not finding a program.
At every published tier, yes. Astra is $68/month for semaglutide and $118/month for tirzepatide on 12-month plans ($816 and $1,416 per year) — the same price in Des Moines as in every other city and at every dose; Astra never offers a city-specific price or discount. Locally, the lowest published entry point is WellForm MD's $195 first month before it moves to $325/month in person; Longevity DSM's regular ladder runs $199–$599 (semaglutide) and $299–$699 (tirzepatide) per four weeks; Des Moines Plastic Surgery is $499/month introductory, then $799/month. The honest caveat: those local prices bundle in-person extras — body-composition scans, in-clinic injections, dietitian visits — that a telehealth subscription doesn't include.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.